TY - JOUR AU1 - Farnetani, Ginevra AU2 - Fino, Maria Grazia AU3 - Cioppi, Francesca AU4 - Riera‐Escamilla, Antoni AU5 - Tamburrino, Lara AU6 - Vannucci, Matteo AU7 - Rosta, Viktoria AU8 - Vinci, Serena AU9 - Casamonti, Elena AU1 - Turki, Leila AU1 - Degl'Innocenti, Selene AU1 - Spinelli, Matilde AU1 - Marchiani, Sara AU1 - Lotti, Francesco AU1 - Muratori, Monica AU1 - Krausz, Csilla AB - INTRODUCTIONTesticular germ cell tumor (TGCT) is the most frequent malignancy in men of reproductive age.1 Its incidence has risen by 1.5% worldwide in the past two decades, presenting sharp geographic differences with the highest incidence in Caucasian populations.1–3 Thanks to the progress in diagnosis and treatment, TGCT is now highly curable with an overall 5‐year survival rate of 95%.4 The primary treatment is radical inguinal orchiectomy, which can be followed by chemotherapy (CT) and/or radiotherapy (RT), depending on the histology and staging.5 CT usually includes platinum‐based agents, such as carboplatin (CP) or a combination of bleomycin, etoposide, and cisplatin (BEP), while RT is recommended only in seminoma (stage IIA and IIB).5Antineoplastic treatments exert their effect by inducing DNA fragmentation in proliferating cells. Hence, they often lead to spermatogenic impairment (severe oligozoospermia or azoospermia) as a short‐term effect. In the large majority of cases, a full or partial recovery of the spermatogenesis occurs within 2 years from the end of therapy. Although routine semen parameters return or even ameliorate with respect to the pre‐treatment values, concerns have been raised about the potential long‐term effect of oncological treatments on sperm DNA integrity.6The importance of better characterizing the nature and persistence of TI - Long‐term effect of cytotoxic treatments on sperm DNA fragmentation in patients affected by testicular germ cell tumor JF - Andrology DO - 10.1111/andr.13429 DA - 2023-11-01 UR - https://www.deepdyve.com/lp/wiley/long-term-effect-of-cytotoxic-treatments-on-sperm-dna-fragmentation-in-uMVDTiUI5Z SP - 1653 EP - 1661 VL - 11 IS - 8 DP - DeepDyve ER -